Antibody interactions with the capsule of Cryptococcus neoformans - Wikidata - wikimedia - TriplyDB

Antibody interactions with the capsule of Cryptococcus neoformans

Antibody interactions with the capsule of Cryptococcus neoformans

http://www.wikidata.org/entity/Q34004832

about

The Cryptococcus neoformans capsule: a sword and a shield.Cryptococcus neoformans: historical curiosity to modern pathogen A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis.New technology and resources for cryptococcal research Cryptococcus neoformans host adaptation: toward biological evidence of dormancy.Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response.App1: an antiphagocytic protein that binds to complement receptors 3 and 2.Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans.Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth.Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.Spatial and temporal sequence of capsule construction in Cryptococcus neoformans.An alpha-1,3-mannosyltransferase of Cryptococcus neoformans.

P2860

Q24619875-4A141893-6BB8-4525-AE2C-7897B5FC8ADC Q27025924-A32A471B-99BF-43C5-A6B9-EAD3E631637E Q27319842-0FED5367-6710-48A0-841B-00DF482A61AF Q33716133-67EA1A16-84F0-4308-8E51-47A31768706F Q33743568-7977720F-EBB0-4407-97F8-1F090F711773 Q33987858-FF84435D-FA13-4626-A20E-E10903A53F52 Q34042463-672B73E0-3002-4559-A51A-D8141A2F6815 Q34146715-A6F7841F-C3BD-4D15-A346-9BDB217F6E50 Q34388790-B7113AFF-CDE3-4C65-8CDE-F0C2FF0E6AD8 Q35611515-E5EED9D1-8710-4A26-986E-081363902A75 Q35677428-12404556-118B-4C7D-BB62-15EBD9811872 Q37074706-6B2A0F71-7A2A-4656-8966-0BC024C3904D Q37158727-17912C06-8D14-4E7C-815A-63957CA2D0C0 Q37421581-B61E8740-E5C8-4D3E-B275-8B94ABE8CE1B Q37551491-3F47BFA5-DEA2-42D3-BF19-E93C47AFFB2B Q39516816-1F071FFE-1609-4DE5-B14F-EF9B5316E8FE Q39517451-3D468CFF-41BA-4BF0-8EB3-BC7E4F810726 Q39520077-CF0381C4-B3E0-47DB-8982-C6C8D1B7E33E Q40339381-3356EA53-5CA0-4D29-B2D2-BF1D1177144E Q43674761-6E3753A8-AEC0-406A-B357-9E326FED0464 Q48227152-366DEEB0-4E96-4F45-850F-A2A40999F153

P2860

Antibody interactions with the capsule of Cryptococcus neoformans

http://www.wikidata.org/entity/Q34004832

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Antibody interactions with the capsule of Cryptococcus neoformans

@ast

Antibody interactions with the capsule of Cryptococcus neoformans

@en

Antibody interactions with the capsule of Cryptococcus neoformans

@nl

type

label

Antibody interactions with the capsule of Cryptococcus neoformans

@ast

Antibody interactions with the capsule of Cryptococcus neoformans

@en

Antibody interactions with the capsule of Cryptococcus neoformans

@nl

prefLabel

Antibody interactions with the capsule of Cryptococcus neoformans

@ast

Antibody interactions with the capsule of Cryptococcus neoformans

@en

Antibody interactions with the capsule of Cryptococcus neoformans

@nl

P1433

Q34004832-8FFB7C25-6817-451A-9927-3B43D66C8C07

P1476

Q34004832-C0A07F9E-20D7-494D-A157-5780AAC18D08

P2093

Q34004832-031B9CE0-0EF2-4EB9-BC4C-A2BAD2569E73

Q34004832-58522C26-C166-47FA-AF19-06B8AF9E56D8

Q34004832-C222E014-5BE3-4553-8071-0A5466EB8690

Q34004832-E911DC21-33F2-4E8D-911D-A3EFF01C27D2

P2860

Q34004832-0277E716-68D4-45A0-A7D1-F27238784103

Q34004832-1B69452D-37F6-415E-8ED5-C13DFFBEA2B7

Q34004832-2078BAC9-7180-4287-AA14-B180C58382C3

Q34004832-247B2D78-CCE7-44DC-BC01-65F8B904A8BC

Q34004832-2DE2B110-8321-4BDE-9ACF-34111395C70E

Q34004832-31FD189E-CD09-4CEB-97EF-54DE108688E8

Q34004832-3211BBB8-CBDB-4B83-8EF4-FE3FC23911AD

Q34004832-330A7D40-F890-41AE-ABD1-58FDE9A1F78A

Q34004832-34579B65-F803-46EE-BE9C-33D0917FE58E

Q34004832-3DD8F466-DBE1-401D-8464-7F82BB78A87B

P304

Q34004832-6BAEB7B0-EE67-46C8-88E9-0B385EC5F11B

P31

Q34004832-FA9BCA71-B02F-4108-BA30-0B2D182BB444

P356

Q34004832-3D826E0E-8D11-461B-BFAA-47969A63765E

P407

Q34004832-2DA68AB2-2B41-41BB-984A-826A87D64833

P433

Q34004832-56D31AC9-24C6-44C0-ADDE-322650D6DEA1

P478

Q34004832-81ACA07F-BE59-4425-9AA9-15698EBD59DE

P50

Q34004832-67321ea7-48b3-8ca1-16db-e34e9f682ccc

P577

Q34004832-59D60A38-91EF-420B-AE0E-75595173EC7D

P698

Q34004832-28CBDEB1-F1DC-4DD9-8FAD-A9248EB4B4CA

P921

Q34004832-F1CA45D5-A96F-4FDD-9AF8-7569C36BEB33

P932

Q34004832-4EF8589E-3746-41B9-8E45-F91DD6E9C36E

P356

IAI.68.6.3642-3650.2000

P1433

Infection and Immunity

P1476

Antibody interactions with the capsule of Cryptococcus neoformans

@en

P2093

A Casadevall

http://www.w3.org/2001/XMLSchema#string

J Rivera

http://www.w3.org/2001/XMLSchema#string

M Feldmesser

http://www.w3.org/2001/XMLSchema#string

Y Kress

http://www.w3.org/2001/XMLSchema#string

P2860

Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation.

Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule

Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection

Genetic control of susceptibility to Cryptococcus neoformans in mice.

The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.

The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody

Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide

Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.

Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.

P304

3642-3650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.68.6.3642-3650.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Thomas R. Kozel

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10816523

http://www.w3.org/2001/XMLSchema#string

P921

P932

97654

http://www.w3.org/2001/XMLSchema#string